India has complained to the World Trade Organisation against some of the European nations confiscating Indian generic drugs being shipped to South America and Africa via Europe.
The pharma industry tracking body, the US-based IMS Health, has highlighted that pharma sales in the US are likely to decline by 1-2% y-o-y this year.
The pharmaceutical logistics business is poised to grow at a faster pace in the near future with the growth of generic market opportunities the Indian companies expected to leverage in the regulated western markets, say supply chain experts.
GlaxoSmithKline (GSK) is closely monitoring the situation regarding the emergence of a new influenza A (H1N1) strain in Mexico, the United States of America, Canada, France, Spain and New Zealand. The World Health Organization (WHO) has stated that the current situation constitutes a public health emergency of international concern and they have raised their level of influenza surveillance globally.
US FDA authorizes emergency use of flu medicines, diagnostic test to tackle Swine flu outbreak in hu
The US Food and Drug Administration, in response to requests from the US Centers for Disease Control and Prevention, has issued Emergency Use Authorizations Read more: (EUAs) to make available to public health and medical personnel important diagnostic and therapeutic tools to identify and respond to the swine flu virus under certain circumstances. The agency issued these EUAs for the use of certain Relenza and Tamiflu antiviral products, and for the rRT-PCR Swine Flu Panel diagnostic test.
Ministry of Indigenous Medicine and the Department of Ayurveda, Sri Lanka, is organizing the 'Ayurveda 2009'- the biggest international exhibition and symposium on indigenous healthcare in Sri Lanka at the Bandaranaike Memorial International Conference Hall (BMICH), Colombo from May 23 – 25 2009.
San Diego-based Ardea Biosciences is pocketing a $35 million upfront payment and stands to earn another $372 million in milestones from a cancer drug development pact that it struck with Bayer HealthCare.
GlobaL pharma giant Pfizer has emerged as the frontrunner to acquire RFCL’s animal health unit, Vetnex, in a deal estimated around Rs 250 crore, people familiar with the situation said. This follows the ICICI Venture-controlled RFCL’s move to divest its animal health business earlier this year.
Sun Pharmaceutical, a Mumbai-based Rs 3350 crore pharmaceutical giant and India's fastest growing international speciality pharma company, has received award in Outstanding Pharmaceuticals, Healthcare & Life Sciences category at the 3rd DHL and CNBC-TV18 International Trade Awards 2008-2009. These awards recognise the efforts of organisations and individuals who have driven India's growth engine in global trade and taken 'Brand India' to the world.
Pharmaceutical firms are defying a broad-based slowdown in Indian exports. Growing demand for cheap, generic drugs is proving a particular boon, reflected in a 46% year-on-year rise in exports to the U.S. during December, the last month for which finalized data are available.Firms hope to capture a share of the $100 billion worldwide market for generic drugs.
Contract manufacturing is one of the best options for the global pharma companies to look forward to in the wake of global recession. The attraction for the global companies to choose India as the ideal hub for contract manufacturing is the opportunity of submission of increasing number of drug master files which has grown to almost 46 per cent in 2007 from a mere 14 per cent in 2000.
Good growth prospects, high current prices, lack of support from financial institutions will translate to lukewarm response to the open offers.
Governments efforts to bring in affordable patented medicines for chronic and lifestyle ailments may hit a roadblock with multinational companies trying to stall the more.
India has started a diplomatic exercise to counter a ‘propaganda’ by multinational pharmaceutical companies against Indian generics or off-patent drugs exported to Africa.
Pfizer Inc and Medicines for Malaria Venture (MVV) have signed an agreement that is designed to facilitate advancements in the battle against malaria, a disease that afflicts vulnerable populations in the developing world each year.
Sun Pharmaceutical Industries US arm has obtained a final approval from US Food and Drug Administration (US-FDA) to market Bethanechol Chloride drug on prescription basis.
The US Food and Drug Administration approved Simponi (golimumab), a monthly treatment for adults with moderate-to-severe rheumatoid arthritis, active psoriatic arthritis, and active ankylosing spondylitis.
The pharmaceutical and biotechnology industry is in the process of consolidating and down-sizing while trying to maintain R&D productivity. Small and medium-sized companies are trying to make the most of available opportunities in niche segments.
The Indian government's aggressive campaign to counter the multinational companies' (MNCs) propaganda against the Indian generic drugs in African countries will start on April 24 in Delhi with an interactive 'clarification meeting' between Indian authorities and the diplomats from the African countries. Ambassadors and high commissioners of African countries in India are participating in the meeting.
Increased price erosion and market saturation in US, EU and Asia-Pacific countries have forced Indian pharma majors to look at Japan, which is the world's second largest market for generics after US. Companies plan to cash in on the lucrative generics space as a logical progression in their international forays.